Menopause Hormone Therapy (HRT) in Lake Elsinore, CA

Bioidentical hormones in Lake Elsinore: what it means

"Bioidentical" describes a hormone whose chemical structure matches one the body makes. Two hormones used in menopause care fit it exactly, estradiol and micronized progesterone. Both come in FDA-approved prescription forms, from estradiol pills, patches, gels and vaginal forms to progesterone capsules.

Only 1 OB-GYN lists a primary practice address in Lake Elsinore in the NPI registry. For 71,516 residents that is 1.4 per 100,000, under the US 17.8 and below California's 16.9. Set against the city's 8,158 women aged 45 to 64, that is one OB-GYN for roughly every 8,160.

Supply stays thin beyond the city line: 6 OB-GYNs within 10 miles and 306 within 25, only 11.4 per 100,000 of the 2,689,178 people who live in that radius, under the US 17.8. VevaMD is an online option alongside them: a physician licensed in California reviews your intake from Lake Elsinore without an office visit, and an OB-GYN you already see stays your doctor.

"BHRT" often means compounded hormones, a cream, a blend such as Bi-Est or a pellet that a pharmacy mixes for one prescription. They are not FDA-approved, which means the FDA cannot assure their safety or effectiveness. The FDA also says it has no evidence that they are safe and effective, or more effective than approved hormone therapy. A 2020 National Academies review found no rigorous evidence of their safety and effectiveness.

For women in Lake Elsinore, a physician licensed in California can prescribe estradiol (pill, patch, cream or vaginal) and progesterone when they fit your history. There are no pellets. Because the dispensing pharmacy also compounds, you can ask whether your estradiol or progesterone is an FDA-approved product. Two options are compounded for certain: testosterone cream for women and Bi-Est are not FDA-approved.

Then there are pellets, implanted under the skin at a clinic; compounded pellets are not FDA-approved. The Endocrine Society points to a study that found hormone levels well above the expected range in women using them. ACOG advises FDA-approved hormone therapy over compounded preparations.

Sources: FDA: Menopause · FDA: National Academies study of compounded bioidentical hormones (2020) · Endocrine Society position statement on compounded bioidentical hormones (2019) · ACOG Clinical Consensus No. 6, compounded bioidentical menopausal hormone therapy (2023) · CMS NPPES NPI full file, 2026-10-11